March 5, 2014 — Boston Scientific’s Lotus transcatheter aortic valve repair (TAVR) system was implanted for the first time in the United Kingdom at Glenfield Hospital in Leicestershire, U.K. The 23 mm transcatheter gives surgeons control of the valve throughout the keyhole procedure, enabling increased precision and the ability to reposition or retrieve the valve, even after insertion if necessary.
The Lotus procedure to treat aortic stenosis is less invasive than open-heart surgery and does not require general anaesthetic, meaning the patient is fully conscious throughout.
Multiple specialities, including the cardiology team, cardiac surgeons, radiology, nurses and anaesthetic support, worked together to successfully carry out the procedure.
The Lotus valve system employs an Adaptive Seal feature, designed to minimize the paravalvular leakage (PVL).
The system received CE marking in October 2013.
For more information: www.bostonscientific.com
October 23, 2026 
